Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF EARNING PER SHARE (Details)

v3.22.1
SCHEDULE OF EARNING PER SHARE (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 28, 2022
Feb. 28, 2021
Feb. 28, 2022
Feb. 28, 2021
Accounting Policies [Abstract]        
Net income available to common stockholders $ (9,496,311) $ 1,264,998 $ (2,984,670) $ 2,088,044
Effect of dilutive securities: 431,163 606,519
Diluted net income $ (9,496,311) $ 1,696,161 $ (2,984,670) $ 2,694,963
Weighted average common shares outstanding – basic 655,781,078 357,891,040 582,680,746 230,663,175
Series A Preferred $ 1,177,041,100 $ 1,177,041,100
Series B Preferred 5,499,034,800 5,499,034,800
Convertible notes 1,809,848,927   1,809,848,927
Warrants 1,132,733,563   1,132,733,563
Series C Preferred
Series D Preferred
Weighted average common shares outstanding and assumed conversion – diluted 655,781,078 9,976,549,430 582,680,746 9,849,321,565
Basic net income per common share $ (0.01) $ 0.00 $ (0.01) $ 0.01
Diluted net income per common share $ (0.01) $ 0.00 $ (0.01) $ 0.00